TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2015 Financial Results and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/3/2026

1. KRG
2. PBA
3. ALAR
4. CCH:LN
5. META
6. CCHGY
7. PRY:IM
8. PRYMY
9. SPY
10. SKA-B

Go back to TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2015 Financial Results and Business Update

Roth Affirms TG Therapeutics (TGTX) at 'Focus Pick'; Sees Strong Results in 2016

March 8, 2016 11:41 AM EST

Roth Capital reaffirms TG Therapeutics (Nasdaq: TGTX) with a Buy (and Focus Pick) rating and $33 price target following the company's FY15 results report, which was made late Monday.

Joseph Pantginis, Ph.D., commented, The GENUINE Phase III (under SPA) is now enrolling at >150 U.S. sites and complete enrollment is expected by year-end and top-line data in early 2017. TG... More